Sexovid(F 6066)ÀÇ ÛÉÕ° ¹× ìõããë¯Û¡üùÍý¿¡ μÇÑ ìúßÉîÜ Ëþ÷Ð
Clinical Evaluation of the Ovulation and Pregnancy Inducing Action of Sexovid
ãéê©ûÇ, ì°ßÓëÃ,
¼Ò¼Ó »ó¼¼Á¤º¸
ãéê©ûÇ ( ) - ½Å¿õÈ£ »êºÎÀΰú ÀÇ¿ø
ì°ßÓëà ( ) - ùÛìéÜ»ê ߧÜþìÑΡ
KMID : 0358419700130020003
Abstract
The capacity of Sexovid(F6066) to induce ovulation and pregnancy in cases of anovulatory menses and aInenorrhea (1st and 2nd grade) was evaluated in 17 patients. Nine cases (52.9%) ovulated and five cases(29066) conceived; i.e., in 11 patients with anovulatory cycles, five cases ovulated and 3cases became pregnant, in 2 cases with first grade amenorrhea all conceived, in 4 ¡×cases with second ,grade amenorrhea 2cases ovulated.
The optimum dose of Sexovid was found to be 200-400mg daily for 7-10 days each month. The complication of therapy, was amenorrhea continuing for 2-3 months after administration un 5cases o anovu atorymenses.
In addition to 18 patients , with ovulatory infertility, were evaluated. Seven pregnancies occurred.
The administration of Sexovid (100mg daily for 5-6days each month) appears to be useful therapeutic approach to the problem of ,patients with ovulatory infertility.
Ű¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸